-
Davis and colleagues report the results of a one-year, randomized, controlled clinical trial of 814 women not on estrogen therapy from 65 centers in the United States, Canada, Australia, the United Kingdom, and Sweden with hypoactive sexual desire disorder treated with transdermal testosterone, 150 or 300 µg per day, or placebo.
-
Hereditary ovarian cancer syndromes are uncommon, but are most often represented by mutation in BRCA1/2.
-
-
When it comes to choosing an effective contraceptive, many women look to the contraceptive injection depot medroxyprogesterone acetate (DMPA, Depo-Provera Pfizer; New York City, Medroxyprogesterone Acetate Injection, Teva Pharmaceuticals USA; North Wales, PA), say respondents to the 2008 Contraceptive Technology Update Contraception Survey.
-
Where do generic oral contraceptives fit in your facility's formulary? About 70% of participants in the 2008 Contraceptive Technology Update Contraception Survey say their facilities have increased the use of generic oral contraceptives due to budget constraints, up 5% from 2007's statistic.
-
While new methods are gaining favor with women, oral contraceptives (OCs) continue to be a popular method of birth control, say respondents to the 2008 Contraceptive Technology Update Contraception Survey. About 42% of survey participants report over half of their patients leave the office with an OC prescription in hand.
-
To prevent pregnancy and disease in adolescents, health professionals seek to help teens delay sexual activity and increase condom and contraception use among those who are sexually active. Throughout the 1990s, those efforts appeared successful.
-
Use of intrauterine contraception is slowly gaining ground among U.S. women. About 45% of respondents to the 2008 Contraceptive Technology Update Contraception Survey say they inserted six or more devices in the last year, compared to 2007's 40% figure. About 40% reported no insertions in 2008, similar to 2007's statistic.
-
When it comes to oral contraceptives (OCs), what is your current practice when it comes to prescribing pills in extended- or continuous- regimens? More providers are prescribing pills in this manner, say respondents to the 2008 Contraceptive Technology Update Contraception Survey. About 62% say they increased use of such pill regimens in the last year.
-
Using blood pressure, BUN, serum sodium, and presence of peripheral arterial disease as predictors of mortality in heart failure patients, 67% who had 3 or more factors died within 6 months and would qualify for the Medicare hospice benefit.
